A carregar...
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
Niacin is considered to be a powerful drug for the treatment of lipid and lipoprotein abnormalities connected with “residual cardiovascular risk”, which persist in high-risk patients even when the target goals of LDL-C are achieved with statin therapy. Recent large randomized clinical studies – AIM-...
Na minha lista:
| Publicado no: | Med Sci Monit |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Scientific Literature, Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4523006/ https://ncbi.nlm.nih.gov/pubmed/26210594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.893619 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|